PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Davis, Stephen M.
TI  - Results of EPITHET
DP  - 2008 May 01
TA  - MD Conference Express
PG  - 11--12
VI  - 8
IP  - 1
4099  - http://mdc.sagepub.com/content/8/1/11.short
4100  - http://mdc.sagepub.com/content/8/1/11.full
AB  - Intravenous recombinant tissue plasminogen activator (tPA) is recommended for the treatment of acute ischemic stroke within the first 3 hours of stroke onset. The objective of the Echoplanar Imaging Thrombolytic Evaluation Trial [EPITHET] was to evaluate the effect of the administration of tPA 3–6 hours after stroke onset as measured by echoplanar magnetic resonance imaging (MRI), diffusion-weighted MRI, and perfusion-weighted MRI.